Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Revenue - Disaggregation of Revenue (Details)

v3.23.3
Note 6 - Revenue - Disaggregation of Revenue (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue $ 15,290,171 $ 2,630,826 $ 21,123,687 $ 9,080,083
Pharmacy Prescription and Other Revenue, Net of PBM Fees [Member]        
Revenue 9,887,890 0 9,887,890 0
E-Commerce [Member]        
Revenue 2,930,721 2,630,826 8,764,237 9,080,083
Pharmacy Prescription, Other Revenue and E-Commerce [Member]        
Revenue 12,818,611 2,630,826 18,652,127 9,080,083
Pharmacy 340B Contract [Member]        
Revenue $ 2,471,560 $ 0 $ 2,471,560 $ 0